Alkermes is the first drugmaker to announce it will leave Second Sight Solutions’ 340B ESP contract pharmacy clearinghouse to switch to drug industry vendor Kalderos’ new Truzo platform.
Alkermes 1st to Shift from 340B ESP to Kalderos’ Truzo Contract Pharmacy Platform; Providers Pan Transition Deadline
Covered entities purchasing 340B-priced Alkermes products will have to submit claims data for the first time and do so via [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
